04/16/2024
11:15 PM | Passage Bio (Filer)
| Form EFFECT | |
04/12/2024
4:35 PM | ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
| Form SC 13D/A | |
04/09/2024
8:35 AM | Passage Bio (Filer)
| Form DEFA14A | |
04/09/2024
5:00 AM | Passage Bio (Filer)
| Form ARS | |
04/09/2024
5:02 AM | Passage Bio (Filer)
| Form DEF 14A | |
03/29/2024
3:15 PM | Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
| Form SC 13G | |
03/04/2024
6:15 AM | Passage Bio (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
03/04/2024
6:02 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:06 PM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:21 AM | Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
| Form SC 13G/A | |
02/13/2024
6:34 PM | Forman Mark S (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:36 PM | Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
3:15 PM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
6:05 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:15 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
4:27 PM | Passage Bio (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
08/07/2023
6:15 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
6:18 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023
4:34 PM | Passage Bio (Issuer)
Sondhi Dolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2023
5:33 PM | Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/28/2023
5:34 PM | Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2023
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
3:36 PM | ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
| Form SC 13D/A | |
06/29/2023
3:42 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:10 PM | Fotopoulos Alexandros (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
9:25 AM | Frazier Life Sciences IX, L.P. (Filed by)
Passage Bio (Subject)
| Form SC 13D/A | |
05/26/2023
3:38 PM | Passage Bio (Issuer)
Woiwode Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
3:22 PM | Countouriotis Athena (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
3:24 PM | GOWEN MAXINE (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
3:26 PM | Islam Saqib (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
6:09 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
6:12 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
